Form D · Other

Gaingels Molecule LLC

Burlington, VT · CIK 0001923844

Offering snapshot reported Jan 27, 2023 · SEC filing

Reported sold
$246K
Offering amount: $246K
Investors reported
22
Form D · investor count
Minimum accepted
$1K
Reported outside-investor minimum
First sale
May 17, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$123K$246KMay 23, 2022: $221,907.00May 23, 2022Jan 27, 2023: $246,201.00Jan 27, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$221,907 → $246,201
  • Reported investors21 → 22

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 27, 2023Amendment$246,201$24,294vs May 23, 202222SEC filing
May 23, 2022Initial$221,907No comparison21SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-446560

Source: Form D, filed Jan 27, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

GAINGELS MOLECULE LLC

Investment adviser: GAINGELS VENTURES LLC

Gross asset value
$100K
Beneficial owners
45
ADV minimum commitment
$1K

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator GAINGELS INC NEW YORK, New York, United States Investor statements: No (provided to no investors) Related to adviser: No
Custodian SILICON VALLEY BANK SANTA CLARA, California, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Filing source

Form ADV 2082471 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-7717218122

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
David Beatty Executive

Issuer details

Industry: Other (See others in industry)

Address:
3 Main Street Suite 214
Burlington, VT, 05401